21 min. Read
10.09.20

Five pharma companies talk digital therapeutic partnerships, DTx pricing, and more

At the recent (virtual, of course) DTx East event, which is typically held in Cambridge, MA, five pharma executives discussed the current state of digital therapeutics. This was probably the best panel at the event and it covered a range of important topics:

  • How far along pharma companies view digital therapeutics
  • Advice for approaching pharma companies for collabs
  • When do pharma companies build

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
New wearable BP 510(k) sheds light on Whoop-FDA. Trials: BetterHelp, Click, DynamiCare, Axena, Kaiser
8.08.25
8 min. Read
CMS RFI review: 12 ideas from health tech cos
7.25.25
10 min. Read
CMS proposes changes to digital mental health G codes, four year test of online DPP reimbursement.
7.16.25
10 min. Read
Digital mental health G code adoption “slow and challenging”
7.11.25
9 min. Read
FDA clears Lumosity-maker’s DTx for ADHD. Withings 510(k) for ECG app.
6.16.25
5 min. Read
PHTI’s premature PDT pricing analysis. CPT billing code rejects.
5.23.25
7 min. Read
PDT bill is back. Anthem covers Luminopia. FDA PCCP for Cognoa.
5.16.25
7 min. Read
More Mahana assets acquired. Luminopia FDA details
5.02.25
7 min. Read
Is it enough? Early MAC pricing for new digital mental health treatment code
4.18.25
6 min. Read
Scoop: Whoop’s first FDA clearance (and what will likely be its second)
4.10.25
7 min. Read
  • First
  • Previous
  • 1 of 23
  • Next
  • Last